Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgicel in Preventing Recurrence of Ovarian Endometriomas
NCT02947724Phase 2Completed
- Sponsor
- Cairo University
- Start
- Jan 2016
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (4 arms), sponsored by Cairo University. Primary endpoint: Recurrence of endometriomas in the ipsilateral ovary at 2 years. Started Jan 2016; status: completed.
Beyond the preview
Go deeper on NCT02947724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02947724.